Lise Lotte Gluud

Lise Lotte Gluud

Clinical Professor

Member of:

  • Internal Medicine: Gastroenterology and Hepatology


Publication year:
All
71 - 80 out of 158Page size: 10
Sort by: 1st author
  1. Published

    Effects of glucagon-like peptide-1 on glucagon secretion in patients with non-alcoholic fatty liver disease

    Junker, A. E., Gluud, Lise Lotte, van Hall, Gerrit, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, Apr 2016, In: Journal of Hepatology. 64, 4, p. 908–915

    Research output: Contribution to journal › Journal article › Research › peer-review

  2. Published

    Influence of gastrointestinal factors on glucose metabolism in patients with cirrhosis

    Junker, A. E., Gluud, Lise Lotte, Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, Tina, Oct 2015, In: Journal of Gastroenterology and Hepatology. 30, 10, p. 1522-8 7 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  3. Published

    Dopamine agents for hepatic encephalopathy

    Junker, A. E., Als-Nielsen, B., Gluud, C. & Gluud, Lise Lotte, 2014, In: Cochrane Database of Systematic Reviews. 2, p. 1-37 37 p., CD003047.

    Research output: Contribution to journal › Review › Research › peer-review

  4. Published

    A 25-year-old woman with type 2 diabetes and liver disease

    Junker, A. E., Gluud, Lise Lotte, Pedersen, J., Langhoff, J. L., Holst, Jens Juul, Knop, Filip Krag & Vilsbøll, T., 2014, In: Case Reports in Gastroenterology. 8, 3, p. 398-403 6 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  5. Published

    Systematic review with meta-analysis: the effects of rifaximin in hepatic encephalopathy

    Kimer, N., Krag, A., Møller, S., Bendtsen, Flemming & Gluud, Lise Lotte, Jul 2014, In: Alimentary Pharmacology and Therapeutics. 40, 2, p. 123-132 10 p.

    Research output: Contribution to journal › Review › Research › peer-review

  6. Published

    Safety, efficacy, and patient acceptability of rifaximin for hepatic encephalopathy

    Kimer, N., Krag, A. & Gluud, Lise Lotte, 2014, In: Patient Preference and Adherence. 8, p. 331-338 8 p.

    Research output: Contribution to journal › Review › Research › peer-review

  7. Published

    Tunneled peritoneal catheter for refractory ascites in cirrhosis: A randomized case-series

    Kimer, N., Nordheim Riedel, A., Hobolth, L., Mortensen, C., Madsen, Lone Galmstrup, Andersen, M. L., Schiødt, Frank Vinholt, Møller, Søren & Gluud, Lise Lotte, 2020, In: Medicina. 56, 11, 9 p., 565.

    Research output: Contribution to journal › Journal article › Research › peer-review

  8. Published

    Rifaximin has no effect on hemodynamics in decompensated cirrhosis: A randomized, double-blind, placebo-controlled trial

    Kimer, N., Pedersen, J. S., Busk, T. M., Gluud, Lise Lotte, Hobolth, L., Krag, A., Møller, Søren, Bendtsen, Flemming & Copenhagen Rifaximin (CoRif) Study Group, C. R. (. S. G., Feb 2017, In: Hepatology. 65, 2, p. 592-603

    Research output: Contribution to journal › Journal article › Research › peer-review

  9. Published

    The Psychometric Hepatic Encephalopathy Syndrome score does not correlate with blood ammonia, endotoxins or markers of inflammation in patients with cirrhosis

    Kimer, N., Gluud, Lise Lotte, Pedersen, J. S., Tavenier, J., Møller, Søren & Bendtsen, Flemming, 2021, In: Translational Gastroenterology and Hepatology. 6, 9 p.

    Research output: Contribution to journal › Journal article › Research › peer-review

  10. Published

    MR-skanning til diagnostik af nonalkoholisk fedtleversygdom

    Kirkegaard-Klitbo, D. M., Danielsen, K. V., Hanson, L. G., Gluud, Lise Lotte, Siebner, Hartwig Roman, Bendtsen, Flemming & Benfield, Thomas, 2019, In: Ugeskrift for Laeger. 181, 9, 5 p., V11180792.

    Research output: Contribution to journal › Journal article › Research › peer-review

Previous 1...4 5 6 7 8 9 10 11 ...16 Next

ID: 4370646